195 related articles for article (PubMed ID: 27639663)
1. Pituitary adenoma associated with pheochromocytoma/paraganglioma: A new form of multiple endocrine neoplasia.
Guerrero Pérez F; Lisbona Gil A; Robledo M; Iglesias P; Villabona Artero C
Endocrinol Nutr; 2016 Nov; 63(9):506-508. PubMed ID: 27639663
[No Abstract] [Full Text] [Related]
2. [Rare forms of hereditary endocrine neoplasia: co-existence of pituitary adenoma and pheochromocytoma/paraganglioma].
Mamedova EO; Lisina DV; Belaya ZE
Probl Endokrinol (Mosk); 2023 May; 69(2):24-30. PubMed ID: 37448268
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice.
Xekouki P; Szarek E; Bullova P; Giubellino A; Quezado M; Mastroyannis SA; Mastorakos P; Wassif CA; Raygada M; Rentia N; Dye L; Cougnoux A; Koziol D; Sierra Mde L; Lyssikatos C; Belyavskaya E; Malchoff C; Moline J; Eng C; Maher LJ; Pacak K; Lodish M; Stratakis CA
J Clin Endocrinol Metab; 2015 May; 100(5):E710-9. PubMed ID: 25695889
[TBL] [Abstract][Full Text] [Related]
4. 15 YEARS OF PARAGANGLIOMA: The association of pituitary adenomas and phaeochromocytomas or paragangliomas.
O'Toole SM; Dénes J; Robledo M; Stratakis CA; Korbonits M
Endocr Relat Cancer; 2015 Aug; 22(4):T105-22. PubMed ID: 26113600
[TBL] [Abstract][Full Text] [Related]
5. Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma.
Dwight T; Mann K; Benn DE; Robinson BG; McKelvie P; Gill AJ; Winship I; Clifton-Bligh RJ
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1103-8. PubMed ID: 23633203
[TBL] [Abstract][Full Text] [Related]
6. 3P association (3PAs): Pituitary adenoma and pheochromocytoma/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutations.
Guerrero-Pérez F; Fajardo C; Torres Vela E; Giménez-Palop O; Lisbona Gil A; Martín T; González N; Díez JJ; Iglesias P; Robledo M; Villabona C
Eur J Intern Med; 2019 Nov; 69():14-19. PubMed ID: 31431315
[TBL] [Abstract][Full Text] [Related]
7. Endocrine tumors as part of inherited tumor syndromes.
Zhang Y; Nosé V
Adv Anat Pathol; 2011 May; 18(3):206-18. PubMed ID: 21490438
[TBL] [Abstract][Full Text] [Related]
8. Paraganglioma genes.
Chew SL
Clin Endocrinol (Oxf); 2001 May; 54(5):573-4. PubMed ID: 11380486
[No Abstract] [Full Text] [Related]
9. The multiple endocrine neoplasia syndromes.
Brunt LM; Wells SA
Invest Radiol; 1985 Dec; 20(9):916-27. PubMed ID: 2867065
[No Abstract] [Full Text] [Related]
10. An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline
Alzahrani AS; Bin Nafisah A; Alswailem M; Moria Y; Poprawski D; Al-Hindi H; Pacak K
Front Endocrinol (Lausanne); 2023; 14():1273093. PubMed ID: 38152133
[TBL] [Abstract][Full Text] [Related]
11. A founder SDHB mutation in Portuguese paraganglioma patients.
Martins RG; Nunes JB; Máximo V; Soares P; Peixoto J; Catarino T; Rito T; Soares P; Pereira L; Sobrinho-Simões M; Santos AP; Couto J; Henrique R; Matos-Loureiro J; Dias P; Torres I; Lima J
Endocr Relat Cancer; 2013 Dec; 20(6):L23-6. PubMed ID: 24092654
[No Abstract] [Full Text] [Related]
12. Hereditary paraganglioma-pheochromocytoma syndrome.
Sanchez Cifuentes A; Candel Arenas MF; Albarracín Marín-Blazquez A
Med Clin (Barc); 2018 Nov; 151(10):e57-e58. PubMed ID: 29656766
[No Abstract] [Full Text] [Related]
13. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
14. [Familial pheochromocytoma].
Tamura N; Nakao K
Nihon Rinsho; 2006 May; Suppl 1():730-4. PubMed ID: 16776261
[No Abstract] [Full Text] [Related]
15. Germinal defects of SDHx genes in patients with isolated pituitary adenoma.
Mougel G; Lagarde A; Albarel F; Essamet W; Luigi P; Mouly C; Vialon M; Cuny T; Castinetti F; Saveanu A; Brue T; Barlier A; Romanet P
Eur J Endocrinol; 2020 Oct; 183(4):369-379. PubMed ID: 32621582
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
18. Late diagnosis of an index case of SDH-related paraganglioma/pheochromocytoma syndrome.
Sánchez-Pacheco Tardón M; Serrano Corredor S; Carrión A; Mauri M; Yuste A
Endocrinol Nutr; 2012 Feb; 59(2):148-50. PubMed ID: 22138625
[No Abstract] [Full Text] [Related]
19. Childhood phaeochromocytoma and paraganglioma: 100% incidence of genetic mutations and 100% survival.
Hammond PJ; Murphy D; Carachi R; Davidson DF; McIntosh D
J Pediatr Surg; 2010 Feb; 45(2):383-6. PubMed ID: 20152357
[TBL] [Abstract][Full Text] [Related]
20. SDH-related pheochromocytoma and paraganglioma.
Kantorovich V; King KS; Pacak K
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):415-24. PubMed ID: 20833333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]